Khirud Gogoi

Title: Khirud Gogoi: Innovator in Polynucleotide Delivery Systems

Introduction

Khirud Gogoi is a prominent inventor based in San Diego, California. He has made significant contributions to the field of biotechnology, particularly in the area of polynucleotide delivery systems. His innovative work focuses on enhancing the efficiency of delivering genetic materials into cells.

Latest Patents

Khirud Gogoi holds a patent for "Polynucleotides having bioreversible groups." This patent describes methods and compositions for delivering polynucleotides into cells. The invention provides transiently protected polynucleotides that include an anionic charge-neutralizing moiety or group, which may also confer additional functionality. These compounds can effectively enter the cytosol of cells through endocytic or macropinocytic mechanisms. The transient protecting group is designed to be bioreversible, meaning it can be removed by enzymatic activity or passive intracellular methods, such as changes in pH or a reductive environment.

Career Highlights

Khirud Gogoi is affiliated with the University of California, where he continues to advance research in biotechnology. His work has garnered attention for its potential applications in gene therapy and molecular medicine. With a focus on innovative solutions, he aims to improve the delivery of therapeutic agents to target cells.

Collaborations

Khirud Gogoi has collaborated with notable researchers in his field, including Steven F. Dowdy and Bryan R. Meade. These collaborations have further enriched his research and contributed to the development of cutting-edge technologies in polynucleotide delivery.

Conclusion

Khirud Gogoi's contributions to the field of biotechnology, particularly through his patent on polynucleotide delivery systems, highlight his role as an innovator. His work at the University of California and collaborations with esteemed colleagues underscore the importance of his research in advancing medical science.